Developing custom syringes for highly viscous formulations discussed at PFS San Francisco

Partner Content
400x300

SMi Reports: ‘Developing custom syringes for highly viscous formulations’ one of the many topics to be presented at the inaugural Pre-filled Syringes San Francisco Conference on September 14 and 15.

SMi Group is holding the inaugural Pre-filled Syringes San Francisco virtual conference, taking place on the 14th and 15th September 2020, in San Francisco, USA.

Who should attend:

  • Drug-delivery developers
  • Medical Device Engineers
  • Primary Packaging material designers
  • Secondary packagers
  • Smart device developers
  • Training device developers
  • Device-safety solution providers
  • Drug developers

To find out more about The Inaugural Pre-Filled Syringes San Francisco virtual conference please visit: http://www.prefilled-sanfrancisco.com/pharmapr7

The Pre-filled Syringes San Francisco Conference will be presenting a variety of topics, below are some key presentations:

‘Developing custom syringes for highly viscous formulations’

  • Gilead and West are developing a custom cyclic olefin polymer (COP) syringe to enable delivery of viscous formulations through subcutaneous injection needles
  • Due to the high injection forces required, syringe stresses and failure modes had to be well understood to inform design improvements
  • The final syringe design can withstand forces in excess of 500N, while remaining ISO 11040-6 compliant to facilitate fill/finish activities

Walter Goodwin, Device Engineer, Device Development & Clinical Packaging Engineering, Gilead Sciences

‘Connected devices and their potential to deliver user benefits’

  • What are connected systems of devices and why would a sponsor elect to develop a connected system
  • Potential benefits of connected devices and the trade-offs
  • Usability considerations of connected devices

Katie Atkinson, Manager, Human Factors Engineering, Bigfoot Biomedical

‘Post-Market safety reporting (PMSR) for combination products – Implementation’

  • Summary of implemented updates to the guidance for industry
  • Strategies in implementation of PMSR and its application to drugs and devices
  • Industry response and developments - what have we seen in industry already and what is still needed?
  • Case study: implementation of PMSR for a combination product

Khaudeja Bano, Senior Medical Director, Abbott Laboratorie

To register and see brochure with the full workshop agenda, and speaker line-up visit: http://www.prefilled-sanfrancisco.com/pharmapr7

Pre-filled Syringes San Francisco
14TH – 15TH September 2020

Hyatt Centric Fisherman's Wharf, San Francisco

Proudly sponsored by: Credence MedSystems | Mitsubishi Gas Chemical | PHC Corporation | Plastic Ingenuity | Steris | Sumitomo | Zeon Speciality Materials|

For media queries please contact Jinna Sidhu at hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088.

--END—

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Ltd

SMi Ltd